Lysine (K)-Specific Demethylase 5B Proteine (KDM5B)

Histone demethylase that demethylates 'Lys-4' of histone H3, thereby playing a central role in histone code. Zusätzlich bieten wir Ihnen KDM5B Antikörper (117) und viele weitere Produktgruppen zu diesem Protein an.

alle Proteine anzeigen Gen GeneID UniProt
KDM5B 10765 Q9UGL1
KDM5B 75605 Q80Y84
Ratte KDM5B KDM5B 304809  
Direkt bei antikoerper-online bestellen
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Online bestellen
  • orders@antikoerper-online.de

Top KDM5B Proteine auf antikoerper-online.de

Showing 5 out of 6 products:

Katalog Nr. Origin Quelle Konjugat Bilder Menge Anbieter Lieferzeit Preis Details
Insektenzellen Maus His tag „Crystallography Grade“ protein due to multi-step, protein-specific purification process 1 mg Anmelden zum Anzeigen 70 Days
$13,741.67
Details
Insektenzellen Human His tag „Crystallography Grade“ protein due to multi-step, protein-specific purification process 1 mg Anmelden zum Anzeigen 70 Days
$13,741.67
Details
Wheat germ Human GST tag 10 μg Anmelden zum Anzeigen 11 bis 12 Tage
$414.29
Details
Insect cells (Sf9) Human DYKDDDDK Tag JARID1B / KDM5B activity assay. Recombinant JARID1B / KDM5B activity measured using a demethylation assay. MALDI-TOF was used for detection. Recombinant JARID1B / KDM5B enzymatic assay. Demethylase activity of JARID1B / KDM5B was measured with an enzymatic assay. MALDI-TOF was used for detection. Catalytic rate: 20 turnovers/enzyme/hour. 20 μg Anmelden zum Anzeigen 1 bis 2 Tage
$478.33
Details
Baculovirus infected Insect Cells Maus GST tag   20 μg Anmelden zum Anzeigen 1 bis 2 Tage
$309.10
Details

KDM5B Proteine nach Spezies und Herkunft

Origin Exprimiert in Konjugat
Human , ,
, ,
Mouse (Murine) , , ,
,

Weitere Proteine zu Lysine (K)-Specific Demethylase 5B (KDM5B) Interaktionspartnern

Human Lysine (K)-Specific Demethylase 5B (KDM5B) Interaktionspartner

  1. These results enlighten an important role of a miRNA's circuit in regulating JARID1B's activity and suggest new perspectives for epigenetic therapies.

  2. High JARID1B expression is associated with Osteosarcoma.

  3. In the HCC cell line, Hep3B, KDM5B expression promoted promote tumor cell proliferation and colony formation. Increased expression of KDM5B in HCC tissues, compared with adjacent normal liver tissues, and was associated with larger tumor size, advanced TNM stage, and reduced overall survival in patients with HCC.

  4. Data reinforces the recent observation that the KDM5B haploinsufficiency is not a mechanism involved in intellectual disability and that KDM5B disorder associated with loss of heterozygosity variants is a recessive disorder.

  5. Altered splicing of JARID1B may be important factor increasing melanoma aggressiveness.

  6. both KDM5A and KDM5B are involved in the lengthening of DICER1

  7. HBx activates the histone demethylase KDM5B and induces hepatic progenitor cell-like features in hepatocellular carcinoma

  8. JARID1B directly bound to PI3K/AKT signaling inhibitor SHIP1 gene promoter and decreased SHIP1 gene expression.

  9. We established the function of JARID1B in mediating the cancer stem cell potential of G0-like cells and our results expand understanding of its context-specific roles in malignant and normal stem cell homeostasis

  10. KDM5B is up-regulated in esophageal squamous cell carcinoma cells.MiR-194 targets KDM5B to inhibit esophageal squamous cell carcinoma development and progression.

  11. Study identified USP15 as having recurrent de novo loss of function mutations and discovered evidence supporting two other known genes with recurrent de novo variants (FOXP1 and KDM5B).

  12. research suggests that miR424-5p may act as a novel anti-oncogene in cervical cancer by blocking cell growth through targeting KDM5B-Notch pathway

  13. JARID1B is involved in the pathogenesis of glioma.

  14. PLU-1 was overexpressed in colorectal cancer tissue compared with healthy colon. PLU-1 expression positively correlated with colorectal cancer progression.

  15. Hsa-miR-448 disrupting KDM5B-MALAT1 signalling axis and associated activities in TNBC cells, projects it as a putative therapeutic factor for selective eradication of TNBC cells.

  16. data indicate that parallel immunohistochemical assays of the expression levels of all the isoforms and of the RBP2-H1 variant of JARID1B may be an efficient technique of differentiating between benign naevi and melanomas

  17. KDM5B, a histone demethylase known to be involved in breast cancer tumorigenesis, as a target of miR-137.

  18. Data show that KDM5B is frequently up-regulated in hepatocellular carcinoma tissues and cell lines and correlated with poor prognosis. Its depletion leads to highly impaired clonogenesis and cell cycle arrest through up-regulation of p15 and p27.

  19. the presented data suggest a mechanism through which Ikaros and HDAC1 regulate the epigenetic signature in leukemia: via regulation of JARID1B transcription.

  20. Characterization of a Linked Jumonji Domain of the KDM5/JARID1 Family of Histone H3 Lysine 4 Demethylases.

Mouse (Murine) Lysine (K)-Specific Demethylase 5B (KDM5B) Interaktionspartner

  1. JARID1B bound to NFkB promoter and affected NFkB expression, resulting in the up-regulation of VEGF-A, promoting proliferation and migration of pulmonary arterial smooth muscle cells in mice with chronic hypoxia-induced pulmonary hypertension.

  2. KDM5B, which demethylates H3K4me3, plays an integral role in regulating RNAPII occupancy, transcriptional initiation and elongation, and alternative splicing events in embryonic stem cells.

  3. data suggest Kdm5b negatively regulates neurogenesis and represses reelin in neural stem cells from the adult subventricular zone.

  4. These results suggest that KDM5B acts to repress type I IFN and other innate cytokines to promote an altered immune response following Respiratory syncytial virus infection that contributes to development of chronic disease.

  5. findings demonstrate that dissociation of the GAPDH/Siah1 pro-apoptotic complex can block high glucose-induced pericyte apoptosis, widely considered a hallmark feature of DR

  6. Deletion of Jarid1b compromises hematopoietic stem cell (HSC) self-renewal capacity; Jarid1b is a positive regulator of HSC potential.

  7. Mechanistically, JARID1B was required for GATA3 recruitment to the Foxa1 promoter to activate Foxa1 expression.

  8. KDM5B is a barrier to the reprogramming process as evidenced by the accelerated reprogramming of differentiated cells in the absence of Kdm5b.

  9. these studies identified Jarid1b as a negative regulator of hematopoietic stem cell (HSC) activity and Jhdmlf as a positive regulator of HSC activity.

  10. Results suggest a role for Jarid1b in Rb-mediated repression of cell cycle genes during senescence.

  11. results delineate an essential role for Jarid1b-mediated transcriptional control during embryonic stem cell differentiation

  12. The present study demonstrated a functional contribution of PLU1 overexpression with concomitant epigenetic dysregulation in cancer progression.

  13. PLU-1/JARID1B/KDM5B is required for embryonic survival and contributes to cell proliferation in the mammary gland and in ER+ breast cancer cells.

  14. Regions upstream of the promoter repress transcription more effectively in a non-malignant breast cell line as compared to breast cancer cell lines.

  15. Ectopic overexpression of mouse Jarid1B, a Yjr119Cp homolog, greatly diminished H3-(lysine) K4me3 and H3-K4me2 in HeLa cells, suggesting these proteins function as K4 demethylases in vivo.

  16. JARID1b blocks differentiation of multiple lineages from ES cells

Cow (Bovine) Lysine (K)-Specific Demethylase 5B (KDM5B) Interaktionspartner

  1. Histone demethylases KDM3A, KDM4A, and KDM4C were expressed before and after embryonic genome activation, whereas KDM5B was mainly expressed during the blastocyst period.

KDM5B Protein Überblick

Protein Überblick

Histone demethylase that demethylates 'Lys-4' of histone H3, thereby playing a central role in histone code. Does not demethylate histone H3 'Lys-9' or H3 'Lys-27'. Demethylates trimethylated, dimethylated and monomethylated H3 'Lys-4'. Acts as a transcriptional corepressor (By similarity).

Genbezeichner und Symbole assoziert mit KDM5B

  • lysine (K)-specific demethylase 5Ba (kdm5ba)
  • lysine (K)-specific demethylase 5Bb (kdm5bb)
  • lysine demethylase 5B (KDM5B)
  • lysine (K)-specific demethylase 5B (Kdm5b)
  • lysine (K)-specific demethylase 5B (KDM5B)
  • lysine demethylase 5B (Kdm5b)
  • 2010009J12Rik Protein
  • 2210016I17Rik Protein
  • AW556288 Protein
  • cb264 Protein
  • CT31 Protein
  • D1Ertd202e Protein
  • id:ibd5050 Protein
  • Jarid1b Protein
  • jarid1ba Protein
  • jarid1bb Protein
  • mKIAA4034 Protein
  • PLU-1 Protein
  • Plu1 Protein
  • PUT1 Protein
  • Rb-Bp2 Protein
  • RBBP2H1A Protein
  • RGD1565602 Protein
  • wu:fc44h11 Protein
  • wu:fd15c05 Protein
  • zgc:85741 Protein

Bezeichner auf Proteinebene für KDM5B

jumonji, AT rich interactive domain 1B (Rbp2 like) , jumonji, AT rich interactive domain 1Ba (Rbp2 like) , histone demethylase JARID1B-B , jumonji/ARID domain-containing protein 1B-B , lysine-specific demethylase 5B-B , putative DNA/chromatin binding motif , lysine (K)-specific demethylase 5B , Jumonji, AT rich interactive domain 1B (RBP2-like) , jumonji, AT rich interactive domain 1B , lysine-specific demethylase 5B-like , RBP2-H1 , cancer/testis antigen 31 , histone demethylase JARID1B , jumonji/ARID domain-containing protein 1B , lysine-specific demethylase 5B , retinoblastoma-binding protein 2 homolog 1 , retinoblastoma-binding protein 2, homolog 1A , putative DNA/chromatin binding motif 1

GENE ID SPEZIES
327168 Danio rerio
415256 Danio rerio
457630 Pan troglodytes
100011885 Monodelphis domestica
100064707 Equus caballus
100077577 Ornithorhynchus anatinus
100356218 Oryctolagus cuniculus
100483283 Ailuropoda melanoleuca
10765 Homo sapiens
75605 Mus musculus
421168 Gallus gallus
479999 Canis lupus familiaris
100625438 Sus scrofa
540633 Bos taurus
304809 Rattus norvegicus
100723111 Cavia porcellus
Ausgewählte Anbieter für KDM5B Proteine (KDM5B)
Haben Sie etwas anderes gesucht?